Hedge Fund - RA Capital Management
Aerovate Therapeutics Inc. (AVTE)
Holding History Records
No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
---|---|---|---|---|---|
1 | 2023 - Q4 (2023-12-31) | $187,013,913 | 2.92% | 8,263,982 | $14.56 |
2 | 2023 - Q3 (2023-09-30) | $112,142,236 | 2.2% | 8,263,982 | $15.48 |
3 | 2023 - Q2 (2023-06-30) | $141,727,291 | 2.67% | 8,263,982 | $18.27 |
4 | 2023 - Q1 (2023-03-31) | $166,684,517 | 3.77% | 8,263,982 | $23.70 |
5 | 2022 - Q4 (2022-12-31) | $242,134,673 | 4.91% | 8,263,982 | $20.74 |
6 | 2022 - Q3 (2022-09-30) | $137,017,000 | 2.92% | 8,263,982 | $19.07 |
7 | 2022 - Q2 (2022-06-30) | $129,166,000 | 3.44% | 8,263,982 | $13.64 |
8 | 2022 - Q1 (2022-03-31) | $151,479,000 | 3.3% | 8,263,982 | $11.09 |
9 | 2021 - Q4 (2021-12-31) | $97,432,000 | 1.71% | 8,263,982 | $14.45 |
10 | 2021 - Q3 (2021-09-30) | $173,378,000 | 2.4% | 8,263,982 | $15.99 |
11 | 2021 - Q2 (2021-06-30) | $188,667,000 | 3.02% | 8,263,982 | $22.83 |
The displayed share prices are average quarterly stock market prices.